JP2011502968A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502968A5
JP2011502968A5 JP2010531519A JP2010531519A JP2011502968A5 JP 2011502968 A5 JP2011502968 A5 JP 2011502968A5 JP 2010531519 A JP2010531519 A JP 2010531519A JP 2010531519 A JP2010531519 A JP 2010531519A JP 2011502968 A5 JP2011502968 A5 JP 2011502968A5
Authority
JP
Japan
Prior art keywords
preparation according
preparation
luteinizing hormone
concentration
hlh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010531519A
Other languages
English (en)
Japanese (ja)
Other versions
JP5551601B2 (ja
JP2011502968A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/064679 external-priority patent/WO2009056569A1/en
Publication of JP2011502968A publication Critical patent/JP2011502968A/ja
Publication of JP2011502968A5 publication Critical patent/JP2011502968A5/ja
Application granted granted Critical
Publication of JP5551601B2 publication Critical patent/JP5551601B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010531519A 2007-11-01 2008-10-29 Lh液体調製物 Active JP5551601B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07119832 2007-11-01
EP07119832.9 2007-11-01
US448107P 2007-11-28 2007-11-28
US61/004,481 2007-11-28
PCT/EP2008/064679 WO2009056569A1 (en) 2007-11-01 2008-10-29 Lh liquid formulations

Publications (3)

Publication Number Publication Date
JP2011502968A JP2011502968A (ja) 2011-01-27
JP2011502968A5 true JP2011502968A5 (https=) 2011-12-22
JP5551601B2 JP5551601B2 (ja) 2014-07-16

Family

ID=39167502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010531519A Active JP5551601B2 (ja) 2007-11-01 2008-10-29 Lh液体調製物

Country Status (25)

Country Link
US (1) US8664369B2 (https=)
EP (1) EP2219607B1 (https=)
JP (1) JP5551601B2 (https=)
KR (1) KR101513181B1 (https=)
CN (1) CN101842083B (https=)
AU (1) AU2008320844B2 (https=)
BR (1) BRPI0818324B8 (https=)
CA (1) CA2700662C (https=)
CY (1) CY1113121T1 (https=)
DK (1) DK2219607T3 (https=)
EA (1) EA019432B1 (https=)
EC (1) ECSP10010224A (https=)
ES (1) ES2393233T3 (https=)
HR (1) HRP20120660T1 (https=)
IL (1) IL205105A (https=)
MX (1) MX2010004639A (https=)
MY (1) MY153976A (https=)
NZ (1) NZ583991A (https=)
PL (1) PL2219607T3 (https=)
PT (1) PT2219607E (https=)
RS (1) RS52566B (https=)
SI (1) SI2219607T1 (https=)
UA (1) UA101484C2 (https=)
WO (1) WO2009056569A1 (https=)
ZA (1) ZA201001907B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
CN102256618A (zh) 2008-10-17 2011-11-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
JP2011001273A (ja) * 2009-06-16 2011-01-06 Eci Inc eMIPを有効成分とする水溶性製剤
PL2451437T3 (pl) * 2009-07-06 2017-05-31 Sanofi-Aventis Deutschland Gmbh Wodne preparaty insuliny zawierające metioninę
NZ599847A (en) 2009-11-13 2013-09-27 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
RU2553375C2 (ru) * 2010-02-12 2015-06-10 Интас Биофармасьютикалс Лимитед Жидкий состав фолликулостимулирующего гормона
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN102293756A (zh) * 2011-08-24 2011-12-28 蚌埠丰原涂山制药有限公司 一种尿促性素冻干粉针剂及其制备方法
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP2016505601A (ja) * 2012-12-26 2016-02-25 ウォックハート リミテッド 医薬組成物
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN105960249B (zh) 2014-01-09 2021-03-16 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
JP6723921B2 (ja) 2014-01-09 2020-07-15 サノフイSanofi インスリンアナログおよび/またはインスリン誘導体の、グリセリンを含まない安定化された医薬製剤
US9895423B2 (en) 2014-01-09 2018-02-20 Sanofi Stabilized pharmaceutical formulations of insulin aspart
PE20171622A1 (es) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland Formulacion de relacion fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
GB201603280D0 (en) * 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5681302A (en) * 1994-06-14 1997-10-28 Minnesota Mining And Manufacturing Company Elastic sheet-like composite
WO1996029095A1 (en) * 1995-03-21 1996-09-26 Applied Research Systems Ars Holding N.V. Hcg liquid formulations
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
CN1309567A (zh) * 1998-07-23 2001-08-22 伊莱利利公司 Fsh和fsh变体制剂,产品和方法
DE602004019761D1 (de) * 2003-01-08 2009-04-16 Novartis Vaccines & Diagnostic Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
US7387998B2 (en) 2003-03-28 2008-06-17 New York University STQ peptides
CA2518903C (en) * 2003-04-02 2013-02-05 Ares Trading S.A. Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant

Similar Documents

Publication Publication Date Title
JP2011502968A5 (https=)
HRP20120660T1 (hr) Tekuće formulacije lh
HRP20200998T1 (hr) Postupak i sastav za liječenje okularne hipertenzije i glaukoma
FI4374878T3 (fi) Karbetosiinia käsittävä farmaseuttinen koostumus
JP2013543492A5 (https=)
KR101940341B1 (ko) 약학 조성물
JP2015527402A5 (https=)
TWI635874B (zh) 艾妥鈣塞(etelcalcetide)(amg 416)之穩定液體調配物
JP2012519695A5 (https=)
HRP20110444T1 (hr) Formulacije paratiroidnih hormona i njihove uporabe
CN102821782B (zh) 促卵泡激素的液体配制品
JP2021536502A (ja) アミノ酸ベースの栄養素の使用及びそれを含む医薬組成物
JP2015535237A5 (https=)
JP2009521473A5 (https=)
AU2005257722B2 (en) Composition comprising lactic acid and lactoferrin
HRP20140676T1 (hr) Formulacije deoksikolne kiseline i njezinih soli
JP2010518075A (ja) 局所的鼻腔投与のためのオロパタジンの製剤
CA2797658A1 (en) Casein peptide for use in the treatment of uterine infections
HRP20211696T1 (hr) Postupak izrade fluoriranih olefina
CN100553674C (zh) 一种重组人甲状旁腺激素(1-84)药物组合物及其制备方法
AR067047A1 (es) Formulaciones acuosas de acetaminofen para inyeccion.
RU2011134414A (ru) Комбинация фульвовой кислоты для лечения различных состояний и болезней
CN102440957A (zh) 醋酸特利加压素鼻腔喷雾剂及其制备方法
CN101972257B (zh) 一种含有莫西沙星的药物组合物
AR062894A1 (es) Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths)